Plasmon-enhanced circular dichroism spectroscopy of chiral drug solutions.


Journal

The Journal of chemical physics
ISSN: 1089-7690
Titre abrégé: J Chem Phys
Pays: United States
ID NLM: 0375360

Informations de publication

Date de publication:
21 Oct 2023
Historique:
received: 28 07 2023
accepted: 01 10 2023
medline: 23 10 2023
pubmed: 17 10 2023
entrez: 17 10 2023
Statut: ppublish

Résumé

We investigate the potential of surface plasmon polaritons at noble metal interfaces for surface-enhanced chiroptical sensing of dilute chiral drug solutions with nl volume. The high quality factor of surface plasmon resonances in both Otto and Kretschmann configurations enables the enhancement of circular dichroism differenatial absorption thanks to the large near-field intensity of such plasmonic excitations. Furthermore, the subwavelength confinement of surface plasmon polaritons is key to attain chiroptical sensitivity to small amounts of drug volumes placed around ≃100 nm by the metal surface. Our calculations focus on reparixin, a pharmaceutical molecule currently used in clinical studies for patients with community-acquired pneumonia, including COVID-19 and acute respiratory distress syndrome. Considering realistic dilute solutions of reparixin dissolved in water with concentration ≤5 mg/ml and nl volume, we find a circular-dichroism differential absorption enhancement factor of the order ≃20 and chirality-induced polarization distortion upon surface plasmon polariton excitation. Our results are relevant for the development of innovative chiroptical sensors capable of measuring the enantiomeric imbalance of chiral drug solutions with nl volume.

Identifiants

pubmed: 37846957
pii: 2916996
doi: 10.1063/5.0169826
pii:
doi:

Substances chimiques

reparixin U604E1NB3K
Metals 0
Sulfonamides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Auteurs

Matteo Venturi (M)

Department of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.

Raju Adhikary (R)

Department of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.

Ambaresh Sahoo (A)

Department of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.

Carino Ferrante (C)

CNR-SPIN, c/o Dip.to di Scienze Fisiche e Chimiche, Via Vetoio, Coppito (L'Aquila) 67100, Italy.

Isabella Daidone (I)

Department of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.

Francesco Di Stasio (F)

Istituto Italiano di Tecnologia, Via Morego 30, Genova 16136, Italy.

Andrea Toma (A)

Istituto Italiano di Tecnologia, Via Morego 30, Genova 16136, Italy.

Francesco Tani (F)

Max Planck Institute for the Science of Light, Staudtstr. 2, 91058 Erlangen, Germany.

Hatice Altug (H)

Institute of Bioengineering, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne 1015, Switzerland.

Antonio Mecozzi (A)

Department of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.

Massimiliano Aschi (M)

Department of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.

Andrea Marini (A)

Department of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
CNR-SPIN, c/o Dip.to di Scienze Fisiche e Chimiche, Via Vetoio, Coppito (L'Aquila) 67100, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH